Gruschen R. Veldtman

Gruschen R. Veldtman

Auto-generated profile, based on publicly available information

Gruschen R. Veldtman

Corewell Health Adult Congenital Heart Disease Department, Helen DeVos Children's Hospital, Grand Rapids, MI, United States

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Journal of Cardiology
Verified
Journal Article
Closed access
TGTimothy T. Gordon-Walker
Timothy T. Gordon-Walker
KBKevin Bove
Kevin Bove
GVGruschen Veldtman
Gruschen Veldtman

30 June 2021 in ESC Heart Failure
Verified
Journal Article
Open access
PDF file
TATarek Alsaied
Tarek Alsaied
RRRahul H. Rathod
Rahul H. Rathod
JAJamil A. Aboulhosn
Jamil A. Aboulhosn
WBWerner Budts
Werner Budts
JAJeffrey B. Anderson
Jeffrey B. Anderson
GVGruschen R. Veldtman
Gruschen R. Veldtman
Aims The Fontan operation has resulted in improved survival in patients with single-ventricle congenital heart disease. As a result, there is a growing population of teenagers and adults with a Fontan circulation. Many co-morbidities have been increasingly recognized in this population due to the unique features of the Fontan circulation. Standardization of how Fontan co-morbid conditions are defined will help facilitate understanding, consistency and interpretability of research and clinical experience. Unifying common language usage in Fontan is a critical precursor step for data comparison of research findings and clinical outcomes and ultimately accelerating improvements in management for this growing group of patients. This manuscript aimed to create unified definitions for morbidities seen after the Fontan palliation. Methods In association of many congenital heart disease organizations, this work used Delphi methodology to reach a broad consensus among recognized experts regarding commonly used terms in Fontan care and research. Each definition underwent at least three rounds of revisions to reach a final definition through surveys sent to experts in the field of single-ventricle care. Results The process of reaching a consensus on multiple morbidities associated with the Fontan procedure is summarized in this manuscript. The different versions that preceded reaching the consensus are also presented in the Supporting Information. Table 1 represents the final definitions according to the consensus. Conclusions We propose the use of these definitions for clinical care, future research studies, registry development and clinical trials.

1 January 2021 in International Journal of Cardiology
Verified
Journal Article
Closed access
MPMathias Possner
Mathias Possner
TGTimothy Gordon-Walker
Timothy Gordon-Walker
AEAlexander C. Egbe
Alexander C. Egbe
JPJoseph T. Poterucha
Joseph T. Poterucha
CWCarole A. Warnes
Carole A. Warnes
GVGruschen Veldtman
Gruschen Veldtman

1 November 2019 in The American Journal of Cardiology
Verified
Journal Article
Closed access
TATarek Alsaied
Tarek Alsaied
MPMathias Possner
Mathias Possner
ALAdam M. Lubert
Adam M. Lubert
ATAndrew T. Trout
Andrew T. Trout
CSCassandra Szugye
Cassandra Szugye
JDJohnathan R. Dillman
Johnathan R. Dillman

27 October 2020 in Open Heart
Verified
Journal Article
Open access
PDF file
TATarek Alsaied
Tarek Alsaied
RMRyan A Moore
Ryan A Moore
SLSean M Lang
Sean M Lang
VTVien Truong
Vien Truong
ALAdam M Lubert
Adam M Lubert
BGBryan H Goldstein
Bryan H Goldstein
Introduction Single ventricle diastolic dysfunction and hepatic fibrosis are frequently observed in patients with a Fontan circulation. The relationship between adverse haemodynamics and end-organ fibrosis has not been investigated in adolescents and young adults with Fontan circulation. Methods Prospective observational study of Fontan patients who had a cardiac catheterisation. Cardiac MRI with T1 mapping was obtained to measure extracellular volume (ECV), a marker of myocardial fibrosis. Hepatic magnetic resonance elastography was performed to assess liver shear stiffness. Serum biomarkers of fibrosis including matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) were measured. Very high ECV was defined as >30% and elevated serum biomarkers as >75th percentile for each biomarker. Results 25 Fontan patients (52% female) with mean age of 16.3±6.8 years were included. Mean ECV was 28%±5%. There was a significant correlation between ECV and systemic ventricular end-diastolic pressure (r=0.42, p=0.03) and between ECV and liver stiffness (r=0.45, p=0.05). Patients with elevated ECV demonstrated elevations in MMPs and TIMPs. Similarly, patients with elevated MMPs and TIMPs had greater liver stiffness compared with patients with normal levels of these biomarkers. Conclusions In Fontan patients, cardiac magnetic resonance evidence of myocardial fibrosis is associated with diastolic dysfunction, increased liver stiffness and elevated circulating biomarkers of fibrosis. These findings suggest the presence of a profibrotic milieu, with end-organ implications, in some patients with Fontan circulation.

1 October 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
JRJessica Rassart
Jessica Rassart
SASilke Apers
Silke Apers
AKAdrienne H. Kovacs
Adrienne H. Kovacs
PMPhilip Moons
Philip Moons
CTCorina Thomet
Corina Thomet
KLKoen Luyckx
Koen Luyckx